William C. Roberts
Investor Relations Kontakt bei G1 THERAPEUTICS, INC.
Aktive Positionen von William C. Roberts
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| G1 THERAPEUTICS, INC. | Investor Relations Kontakt | 04.01.2021 | - |
| Public Communications Contact | 04.01.2021 | - |
Karriereverlauf von William C. Roberts
Ehemalige bekannte Positionen von William C. Roberts
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Investor Relations Kontakt | - | 23.10.2017 |
| Viropharma, Inc. | Public Communications Contact | - | - |
| ZYNERBA PHARMACEUTICALS, INC. | Investor Relations Kontakt | 01.05.2017 | - |
| Public Communications Contact | 01.05.2017 | - | |
| Medimmune, Inc. | Investor Relations Kontakt | - | - |
Shire ViroPharma, Inc.
 Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Investor Relations Kontakt | - | - |
| Public Communications Contact | 17.06.2010 | - |
Ausbildung von William C. Roberts
| Keller Graduate School of Management | Masters Business Admin |
| University of Virginia | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 8 |
| Vereinigtes Königreich | 2 |
Operativ
| Investor Relations Contact | 5 |
| Public Communications Contact | 4 |
| Masters Business Admin | 1 |
Sektoral
| Health Technology | 6 |
| Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| ADAPTIMMUNE THERAPEUTICS PLC | Health Technology |
| ZYNERBA PHARMACEUTICALS, INC. | Health Technology |
| G1 THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 3 |
|---|---|
Shire ViroPharma, Inc.
Shire ViroPharma, Inc. Pharmaceuticals: MajorHealth Technology Shire ViroPharma, Inc. develops and manufactures drugs. It offers treatment for prophylaxis of hereditary angioedema, as well as capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis. The company was founded by Claude H. Nash and Mark A. McKinlay in September 1994 and is headquartered in Exton, PA. | Health Technology |
| Medimmune, Inc. | Health Technology |
| Viropharma, Inc. |
- Börse
- Insiders
- William C. Roberts
- Erfahrung